In in vivo tumor models, Mysm1-deficient macrophages display characteristics of M1 macrophages and suppress tumor growth, indicating MYSM1’s crucial role in macrophage survival and polarization and meaning it could potentially serve as a target for cell therapy. This evidence concerns the gene MYSM1 and neoplasm.